468 related articles for article (PubMed ID: 1559293)
1. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome.
Kiddy DS; Hamilton-Fairley D; Bush A; Short F; Anyaoku V; Reed MJ; Franks S
Clin Endocrinol (Oxf); 1992 Jan; 36(1):105-11. PubMed ID: 1559293
[TBL] [Abstract][Full Text] [Related]
2. The role of nutrition and insulin in the regulation of sex hormone binding globulin.
Franks S; Kiddy DS; Hamilton-Fairley D; Bush A; Sharp PS; Reed MJ
J Steroid Biochem Mol Biol; 1991 Nov; 39(5B):835-8. PubMed ID: 1954173
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of ovarian functionality after a dietary treatment in obese women with polycystic ovary syndrome.
Tolino A; Gambardella V; Caccavale C; D'Ettore A; Giannotti F; D'Antò V; De Falco CL
Eur J Obstet Gynecol Reprod Biol; 2005 Mar; 119(1):87-93. PubMed ID: 15734091
[TBL] [Abstract][Full Text] [Related]
4. Response of sex hormone binding globulin and insulin-like growth factor binding protein-1 to an oral glucose tolerance test in obese women with polycystic ovary syndrome before and after calorie restriction.
Hamilton-Fairley D; Kiddy D; Anyaoku V; Koistinen R; Seppälä M; Franks S
Clin Endocrinol (Oxf); 1993 Sep; 39(3):363-7. PubMed ID: 7693380
[TBL] [Abstract][Full Text] [Related]
5. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome.
Nestler JE; Powers LP; Matt DW; Steingold KA; Plymate SR; Rittmaster RS; Clore JN; Blackard WG
J Clin Endocrinol Metab; 1991 Jan; 72(1):83-9. PubMed ID: 1898744
[TBL] [Abstract][Full Text] [Related]
6. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
7. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Katsikis I; Piperi C; Alexandraki K; Panidis D
Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808
[TBL] [Abstract][Full Text] [Related]
8. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
Toscano V; Bianchi P; Balducci R; Guglielmi R; Mangiantini A; Lubrano C; Sciarra F
Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
[TBL] [Abstract][Full Text] [Related]
9. Effects of Dietary Approach to Stop Hypertension diet on androgens, antioxidant status and body composition in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial.
Azadi-Yazdi M; Karimi-Zarchi M; Salehi-Abargouei A; Fallahzadeh H; Nadjarzadeh A
J Hum Nutr Diet; 2017 Jun; 30(3):275-283. PubMed ID: 28466507
[TBL] [Abstract][Full Text] [Related]
10. The effect of weight loss on inflammation in obese women with polycystic ovary syndrome.
Olszanecka-Glinianowicz M; Zahorska-Markiewicz B; Kocełak P; Janowska J; Semik-Grabarczyk E
Endokrynol Pol; 2008; 59(1):13-7. PubMed ID: 18335395
[TBL] [Abstract][Full Text] [Related]
11. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.
Huber-Buchholz MM; Carey DG; Norman RJ
J Clin Endocrinol Metab; 1999 Apr; 84(4):1470-4. PubMed ID: 10199797
[TBL] [Abstract][Full Text] [Related]
12. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
Holte J; Bergh T; Gennarelli G; Wide L
Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
[TBL] [Abstract][Full Text] [Related]
13. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
14. The relation between clinical manifestations of polycystic ovary syndrome and beta-cell function.
Weber RF; Pache TD; Jacobs ML; Docter R; Loriaux DL; Fauser BC; Birkenhäger JC
Clin Endocrinol (Oxf); 1993 Mar; 38(3):295-300. PubMed ID: 8458101
[TBL] [Abstract][Full Text] [Related]
15. Effect of Dietary Weight Loss on Menstrual Regularity in Obese Young Adult Women with Polycystic Ovary Syndrome.
Marzouk TM; Sayed Ahmed WA
J Pediatr Adolesc Gynecol; 2015 Dec; 28(6):457-61. PubMed ID: 26298524
[TBL] [Abstract][Full Text] [Related]
16. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.
Robinson S; Henderson AD; Gelding SV; Kiddy D; Niththyananthan R; Bush A; Richmond W; Johnston DG; Franks S
Clin Endocrinol (Oxf); 1996 Mar; 44(3):277-84. PubMed ID: 8729522
[TBL] [Abstract][Full Text] [Related]
17. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.
Pasquali R; Gambineri A; Anconetani B; Vicennati V; Colitta D; Caramelli E; Casimirri F; Morselli-Labate AM
Clin Endocrinol (Oxf); 1999 Apr; 50(4):517-27. PubMed ID: 10468913
[TBL] [Abstract][Full Text] [Related]
18. The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.
Jafari-Sfidvajani S; Ahangari R; Hozoori M; Mozaffari-Khosravi H; Fallahzadeh H; Nadjarzadeh A
J Endocrinol Invest; 2018 May; 41(5):597-607. PubMed ID: 29110281
[TBL] [Abstract][Full Text] [Related]
19. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
Kaltsas GA; Korbonits M; Isidori AM; Webb JA; Trainer PJ; Monson JP; Besser GM; Grossman AB
Clin Endocrinol (Oxf); 2000 Oct; 53(4):493-500. PubMed ID: 11012575
[TBL] [Abstract][Full Text] [Related]
20. Diurnal variation of sex hormone binding globulin and insulin-like growth factor binding protein-1 in women with polycystic ovary syndrome.
Hamilton-Fairley D; White D; Griffiths M; Anyaoku V; Koistinen R; Seppälä M; Franks S
Clin Endocrinol (Oxf); 1995 Aug; 43(2):159-65. PubMed ID: 7554310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]